ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,699,693 | -8.2% | 183,941 | +3.0% | 0.00% | 0.0% |
| Q2 2023 | $5,119,552 | +19.1% | 178,506 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $4,299,643 | +42.0% | 179,376 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $3,028,225 | +19.6% | 178,551 | +4.5% | 0.00% | 0.0% |
| Q3 2022 | $2,532,000 | +2.9% | 170,824 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $2,460,000 | -41.0% | 156,258 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $4,167,000 | -25.4% | 154,551 | +2.5% | 0.00% | -50.0% |
| Q4 2021 | $5,583,000 | -21.9% | 150,847 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $7,146,000 | +46.0% | 149,560 | +3.4% | 0.00% | 0.0% |
| Q2 2021 | $4,894,000 | -14.5% | 144,621 | +4.4% | 0.00% | 0.0% |
| Q1 2021 | $5,722,000 | -2.9% | 138,526 | +2.0% | 0.00% | 0.0% |
| Q4 2020 | $5,893,000 | +17.3% | 135,830 | +16.1% | 0.00% | 0.0% |
| Q3 2020 | $5,022,000 | +219.7% | 117,042 | +248.4% | 0.00% | +100.0% |
| Q2 2020 | $1,571,000 | – | 33,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |